Alpha Cognition Inc
ACOG
Rank in Stocks
#20419
Alpha Cognition Inc., a biopharmaceutical company, engages in the development... Alpha Cognition Inc., a biopharmaceutical company, engages in the development of treatments for patients suffering from neurodegenerative diseases in the United States and Canada. The company's commercial development program includes ZUNVEYL oral tablet formulation for treating Alzheimer's disease. Its pre-clinical development programs comprise ZUNVEYL in combination with memantine for the treatment of moderate-to-severe Alzheimer's disease; ALPHA-1062 sublingual formulation for acute pancreatitis; ALPHA-1062 intranasal formulation for the treatment of cognitive impairment with mild traumatic brain injury; and ALPHA-0602, ALPHA-0702, and ALPHA-0802 programs for the treatment of neurodegenerative diseases, including amyotrophic lateral sclerosis disease and spinal muscular atrophy. The company was founded in 2000 and is headquartered in Vancouver, Canada.
Share Price
$8.13
Last synced: 2026-10-16
Market Cap
$126.27M
Change (1 day)
-3.79%
Change (1 year)
61.63%
Country
US
Trade Alpha Cognition Inc (ACOG)
Category
Healthcare
Market Capitalization of Alpha Cognition Inc(ACOG)
Market Cap: $126.27M
As of October 2026 Alpha Cognition Inc has a market cap of $126.27M. This makes Alpha Cognition Inc the world's 20419th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Alpha Cognition Inc from 2021 to 2026
ACOG compared with Top 5 Most Popular stocks
